Other News To Note

• Genkyotex SA, of Geneva, reported positive results from studies of GKT137831, for liver fibrosis, showing the ability to attenuate development of fibrosis in the liver and attenuate production of reaction oxygen species in two models of the disease.

To continue reading subscribe now to BioWorld Asia (formerly International)